Page 12 - Corporate Earnings

MTAR Tech shares surge after strong Q4 earnings; profit up multifold

MTAR Tech's stock rose as much as 4.83 per cent after it reported a multifold increase in its Q4 net profit

Concor shares drop 4% as Q4 profit, revenue slip; earnings breakdown here

Shares of Container Corporation of India (Concor) fell over 4 per cent on Friday after it reported a marginal decline in its net profit

ITC shares gain 2% after Q4 results; check earnings, brokerage review here

ITC's stock rose as much as 1.98 per cent after it reported a multifold increase in its profit for the fourth quarter

ITC Q4FY25 results: Adjusted profit rises 3% to Rs 5,155.27 crore

ITC reports Rs 5,155 crore adjusted PAT in Q4FY25, with one-time hotel demerger gain pushing reported profit to Rs 19,727 crore amid rising input costs and weak demand

Airtel Payments Bank Q4 net profit jumps 138% to ₹26 crore, revenue up 35%

The payments bank posted revenue of ₹726 crore in Q4FY25, marking a 34.7 per cent increase compared to the same quarter last year

HFCL Q4 results: Net loss at ₹83 crore, revenue declines 39% to ₹800 crore

The Board of Directors has declared a 10 per cent dividend for the financial year 2024-25, translating to ₹0.10 per equity share with a face value of ₹1 each

Sun Pharma Q4 results: Net profit falls 19% to ₹2,153.9 cr, revenue up 8%

Sun Pharma posted a 19% drop in Q4 profit to ₹2,153.9 crore, while revenue rose 8.5%. India formulation sales grew 13.6%, and a ₹5.5 final dividend has been recommended

Emcure Q4 profit jumps 63%, domestic business drives 19.5% revenue rise

Emcure Pharma posted strong March quarter results with 63% rise in net profit and 19.5% growth in revenue, driven by robust domestic demand and global segment performance

Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 cr

Lincoln Pharmaceuticals on Thursday reported a net profit of Rs 11.62 crore for the March quarter of 2024-25 and said it is building a portfolio in lifestyle and chronic segments, particularly in women's healthcare and dermatology. The Ahmedabad-based company in a statement said that it focuses on expanding its global footprint by registering new products for export and also building a portfolio in lifestyle and chronic segments. The pharma company had reported a net profit of Rs 18.8 crore in the year-ago period. Revenue from operations rose to Rs 161.30 crore in the last quarter of FY25 from Rs 149.51 crore in the year-ago period. "The company remain committed to net debt-free and continues to leverage strategic product launches in both domestic and international markets to strengthen our market presence," Lincoln Pharmaceuticals Managing Director Mahendra Patel said. For the full fiscal, the company reported a net profit of Rs 82.44 crore against Rs 93.36 crore in FY24. Total .

Interarch Building Solutions Q4 results: Profit rises 30% to Rs 39 crore

Interarch Building Solutions has posted a 30 per cent increase in its net profit to Rs 38.68 crore for the fourth quarter of the last financial year on higher revenue. Its net profit stood at Rs 29.69 crore in the year-ago period. The total income of Interarch Building Solutions, which is in the Pre-Engineered Building (PEB) industry, rose to Rs 470.58 crore in the January-March period of 2024-25 from Rs 390.23 crore in the corresponding period of the preceding fiscal. During the full 2024-25 fiscal, the company's net profit increased to Rs 107.82 crore from Rs 86.26 crore a year ago, it said in a regulatory filing on Wednesday. Its total income grew to Rs 1,474.47 crore last fiscal, from Rs 1,306.31 crore in 2023-24. Commenting on the company's performance, Interarch Building Solutions Ltd Managing Director Arvind Nanda said the company has reported the highest-ever quarterly and annual financial performance, marked by robust volume growth and improved order execution. "The ...

Colgate-Palmolive shares drop 6% after Q4 earnings; profit, revenue slip

Shares of Colgate-Palmolive (India) fell nearly 6 per cent after it posted a 6.5 per cent decline in its net profit

HG Infra shares slump 9%, log worst day in over a month on weak Q4

Shares of HG Infra Engineering tumbled over 9 per cent after the company reported a 22.65 per cent decline in Q4 profit

Mankind Pharma shares slide 3% as Q4 profit declines; details here

Shares of Mankind Pharma dropped over 3 per cent after it posted a 10 per cent fall in consolidated net profit Q4 FY25

PFC Q4 results: PAT rises 11% to Rs 8,358 crore, dividend at Rs 2.05/share

State-owned Power Finance Corporation on Wednesday posted an 11 per cent rise in its consolidated net profit to Rs 8,357.88 crore for the quarter ended March 31, mainly on the back of higher interest income. The company had posted a net profit of Rs 7,556.43 crore in the corresponding quarter of the previous fiscal, according to a regulatory filing. Total income rose to Rs 29,285.45 crore in the quarter under review, from Rs 24,176.34 crore in the same period a year ago. The interest income in the quarter rose to Rs 28,676.15 crore from Rs 23,891.19 crore in same period a year ago. During FY25, the consolidated net profit rose to Rs 30,514.40 crore from Rs 26,461.18 crore in the previous financial year. Total income in the fiscal year increased to Rs 1,06,598.70 crore, from Rs 91,174.87 crore a year ago. The board recommended a final dividend of Rs 2.05 per equity share (subject to deduction of TDS) on the face value of the paid-up equity shares of Rs 10 each for the FY 2024-2

NHPC Q4 results: PAT rises 52% to Rs 919 crore; FY25 profit slips 15%

State-owned hydropower developer NHPC has reported a 52 per cent growth in its consolidated net profit to Rs 919.63 crore for the March quarter, driven by increased income. It posted a net profit of Rs 605 crore in the January-March period of the preceding 2023-24 fiscal year, the company said in an exchange filing on Tuesday. NHPC increased its income to Rs 2,672.11 crore, from Rs 2,320.18 crore in the same quarter a year ago. However, for the entire FY25, the net profit declined by around 15 per cent to Rs 3,411.73 crore, from Rs 3,999.54 crore in FY24. The company's board has recommended a final dividend of Re 0.51 per equity share of face value Rs 10 for the financial year 202425, subject to shareholders' approval at the upcoming Annual General Meeting. This is in addition to the interim dividend of Rs 1.40 per equity share for the FY 2024-25 paid in March 2025. In April, the company commissioned the 800 MW Parbati-11 HE Project (hydroelectric) and 107.14 MW (out of a total o

IndusInd Bank shares fall 1.5% ahead of Q4; lender likely to post loss

IndusInd Bank's stock fell as much as 1.5 per cent ahead of its fourth quarter earnings

JK Tyre Q4FY25 profit down 42.6% to Rs 97 crore, revenue up 1.63%

JK Tyre's net profit fell 42.6% in Q4FY25 due to raw material inflation; revenue rose modestly, with premium product lines showing strong customer traction

Whirlpool Q4 results: Net profit rises 50% to to ₹119 crore, revenue up 15%

Whirlpool India reported ₹119 crore Q4 profit on strong revenue and a ₹7 crore insurance gain. Full-year profit rose 62%, and a ₹5 per share dividend was announced

Pfizer Q4 net profit jumps 85% to ₹331 crore; revenue rises 8.3%

Pfizer's Q4 profit surged to ₹331 crore, aided by a ₹172 crore gain from land sale; board declares ₹165 dividend per share, including special payouts for FY25

Max Healthcare Q4 net profit rises 26.8% to Rs 319 crore, revenue up 32%

Profit growth driven by higher occupancy, rising Arpob, international patient inflow and new bed additions across Lucknow, Dwarka and BLK Max facilities